This is all you need to know about the new weight loss jab 'Reta' that's said to be 3 times stronger than Ozempic.

Johnson & Johnson announces a $2 billion North Carolina manufacturing expansion as part of a broader U.S. onshore ...

This week on "The Readout LOUD," we discuss Viking Therapeutics' obesity flop and dish on the growing "pharm to table" movement.

The most profitable trades in history often begin in moments of panic. And few moments felt more hopeless than the fall of ...

Our Grant Me Hope child this week is 15-year-old Lilly, who loves being in the water, swimming and being outdoors.

For the second time in the last three weeks, AbbVie has revealed successful results from a phase 3 study of Rinvoq as a treatment for the hair-loss disease alopecia areata (AA). | For the second time ...

Johnson & Johnson said Thursday it will invest $2 billion in North Carolina to expand U.S. manufacturing, according to ...

Hyderabad-based Natco Pharma has filed a lawsuit against Danish drugmaker Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy (semaglutide), before the Delhi High Court.

With the price of Mounjaro set to almost triple in the UK, there are fears more and more people will turn to counterfeits.

The healthcare sector is enduring one of its worst patches on record, thanks to a slew of problems that include managed care costs and stiffening competition among blockbuster weight-loss drugs.

What goes up must come down — here are the major drugs falling the hardest at the top companies so far this year.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...